Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 24 Feb 2015 for NPS PHARMACEUTICALS INC, €299k.
Insider track record
Disclosed buys
0
Disclosed sells
5
Signal history
No signal scores available.
Rachel R. Selisker: trading record in brief
Rachel R. Selisker discloses dealings in NPS Pharmaceuticals Inc to SEC (Form 4). The record holds 12 filings, for trades running from 7 February 2012 to 21 February 2015.
On the market, this insider has only sold: 5 sales, €1.5M in total. The rest of the record consists of 1 share grant and 4 option exercises.
The newest entry dates from 24 February 2015: a transaction of €299k, in NPS Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Rachel R. Selisker
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
7,400 shares@ US$46.00Common StockSEC:0001104659-15-013582:0
1,208 shares@ US$4.24Common StockSEC:0001104659-14-087782:0
3,708 shares@ US$34.59Common StockSEC:0001104659-14-087782:1
23,157 shares@ US$4.24Common StockSEC:0001104659-14-085930:0
23,157 shares@ US$34.50Common StockSEC:0001104659-14-085930:1
11,635 shares@ US$4.24Common StockSEC:0001104659-14-084333:0
11,635 shares@ US$34.50Common StockSEC:0001104659-14-084333:1
15,188 shares@ US$29.50Common StockSEC:0001104659-14-080341:0
15,188 sharesCommon StockSEC:0000890465-14-000049:0
15,225 sharesCommon stockSEC:0001474064-13-000025:0
5,325 shares@ US$8.74Common stockSEC:0001474064-13-000025:1
15,225 shares0Common StockSEC:0001474064-12-000025:0
12 of 12 declarations
